Literature DB >> 17940847

EpCAM homologues exhibit epithelial-specific but different expression patterns in the kidney.

Monika Trzpis1, Pamela M McLaughlin, Eliane R Popa, Peter Terpstra, Theo G van Kooten, Lou M de Leij, Martin C Harmsen.   

Abstract

The Epithelial Cell Adhesion Molecule (EpCAM) is expressed virtually on normal epithelia in vertebrates. Among different species, the amino acid sequence of EpCAM is highly homologous, indicating that EpCAM is an evolutionary conserved protein. However, differences in the expression pattern of EpCAM homologues have been reported. We hypothesized that differences in expression pattern might be related to the promoter organization of the respective EpCAM homologues. Therefore, we here compared the promoter region of the mouse and human EpCAM homologues. In addition, we compared the expression pattern of the human and murine EpCAM homologues in the hEpCAM transgenic mouse. In silico analysis of EpCAM homologues revealed that the amino acid sequence as well as the domain structure is highly conserved throughout different vertebrates. In silico analysis of the promoter region identified that the human and mouse EpCAM promoters share a low homology. In agreement with this low homology, the murine and human EpCAM promoter contains only a few common transcription factor binding sites. Nevertheless, immunohistochemcial analysis of the expression of human and murine EpCAM in lung, colon, and kidney of the hEpCAM transgenic mouse identified that expression of both homologues is restricted to epithelial cells in these organs. Moreover, in lung and colon the human and murine homologues of EpCAM were co-expressed. In contrast, the EpCAM homologues were only sporadically co-expressed in renal epithelia, although they were distributed similarly along the nephronic segments. Together, these findings indicate an overall conserved regulatory mechanism that ensures epithelial expression of EpCAM homologues, despite the low promoter homology. Furthermore, the fact that murine epithelia express the human homologue of EpCAM indicates that the mouse has transcription factors required for human EpCAM expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940847     DOI: 10.1007/s11248-007-9141-8

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  16 in total

1.  Comparing expression profiles of genes with similar promoter regions.

Authors:  Peter J Park; Atul J Butte; Isaac S Kohane
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

2.  A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells.

Authors:  P L Bergsagel; C Victor-Kobrin; C R Timblin; J Trepel; W M Kuehl
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

3.  The murine homolog of human Ep-CAM, a homotypic adhesion molecule, is expressed by thymocytes and thymic epithelial cells.

Authors:  A J Nelson; R J Dunn; R Peach; A Aruffo; A G Farr
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

Review 4.  The biology of the 17-1A antigen (Ep-CAM).

Authors:  M Balzar; M J Winter; C J de Boer; S V Litvinov
Journal:  J Mol Med (Berl)       Date:  1999-10       Impact factor: 4.599

5.  Using protein expressions to predict survival in clear cell renal carcinoma.

Authors:  Hyung L Kim; David Seligson; Xueli Liu; Nicolette Janzen; Matthew H T Bui; Hong Yu; Tao Shi; Robert A Figlin; Steve Horvath; Arie S Belldegrun
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

6.  Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.

Authors:  Viola A Heinzelmann-Schwarz; Margaret Gardiner-Garden; Susan M Henshall; James Scurry; Richard A Scolyer; Michael J Davies; Matthias Heinzelmann; Larry H Kalish; Anish Bali; James G Kench; Lyndal S Edwards; Patricia M Vanden Bergh; Neville F Hacker; Robert L Sutherland; Philippa M O'Brien
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

7.  Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines.

Authors:  Pamela M J McLaughlin; Monika Trzpis; Bart-Jan Kroesen; Wijnand Helfrich; Peter Terpstra; Wim H A Dokter; Marcel H J Ruiters; Lou F M H de Leij; Martin C Harmsen
Journal:  Cancer Gene Ther       Date:  2004-09       Impact factor: 5.987

8.  EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.

Authors:  Walid A Osta; Yian Chen; Kaidi Mikhitarian; Michael Mitas; Mohamed Salem; Yusuf A Hannun; David J Cole; William E Gillanders
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

9.  Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells.

Authors:  T A Borkowski; A J Nelson; A G Farr; M C Udey
Journal:  Eur J Immunol       Date:  1996-01       Impact factor: 5.532

10.  Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells.

Authors:  Edwin Bremer; Douwe Samplonius; Bart-Jan Kroesen; Linda van Genne; Lou de Leij; Wijnand Helfrich
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

View more
  7 in total

1.  Positive Darwinian selection drives the evolution of the morphology-related gene, EPCAM, in particularly species-rich lineages of African cichlid fishes.

Authors:  Shaohua Fan; Kathryn R Elmer; Axel Meyer
Journal:  J Mol Evol       Date:  2011-08-03       Impact factor: 2.395

2.  Arg753Gln Polymorphisms in Toll-Like Receptor 2 Gene are Associated with Tuberculosis Risk: A Meta-Analysis.

Authors:  Hangyu Wu; Li Yang
Journal:  Med Sci Monit       Date:  2015-07-29

3.  IL22 regulates human urothelial cell sensory and innate functions through modulation of the acetylcholine response, immunoregulatory cytokines and antimicrobial peptides: assessment of an in vitro model.

Authors:  Phong T Le; Meghan M Pearce; Shubin Zhang; Edward M Campbell; Cynthia S Fok; Elizabeth R Mueller; Cynthia A Brincat; Alan J Wolfe; Linda Brubaker
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

Review 4.  EpCAM and the biology of hepatic stem/progenitor cells.

Authors:  Laurent Dollé; Neil D Theise; Eva Schmelzer; Luke Boulter; Olivier Gires; Leo A van Grunsven
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

5.  Targeting Liver Cancer Stem Cells Using Engineered Biological Nanoparticles for the Treatment of Hepatocellular Cancer.

Authors:  Kaori Ishiguro; Irene K Yan; Laura Lewis-Tuffin; Tushar Patel
Journal:  Hepatol Commun       Date:  2020-01-03

6.  The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development.

Authors:  Krasimir Slanchev; Thomas J Carney; Marc P Stemmler; Birgit Koschorz; Adam Amsterdam; Heinz Schwarz; Matthias Hammerschmidt
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

7.  Expression of stem cell markers in the human fetal kidney.

Authors:  Sally Metsuyanim; Orit Harari-Steinberg; Ella Buzhor; Dorit Omer; Naomi Pode-Shakked; Herzl Ben-Hur; Reuvit Halperin; David Schneider; Benjamin Dekel
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.